Singapore, March 27 -- The Health Sciences Authority received information related to the study titled 'A Study to Evaluate the Effect of Fasting Duration and Temporary Withholding of Dulaglutide on Retained Gastric Contents Using Gastric Ultrasound in Participants with Type 2 Diabetes Mellitus'. The following are the other relevant details related to the trial:
Therapeutic Area: Clinical Pharmacology
Trial Centre(s):
Lilly Centre for Pharmacology
Trial Status: Ongoing, Recruiting
Principal Investigator(s):
Dr Noel Mathew Varghese
Published by HT Digital Content Services with permission from Health Daily Digest....